NCT01804842View on ClinicalTrials.gov

Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Met DR

metformin delayed-release tablets

Sponsors
All Listed Sponsors
lead

Elcelyx Therapeutics, Inc.

INDUSTRY